Literature DB >> 14711988

Mislocalization to the nuclear envelope: an effect of the dystonia-causing torsinA mutation.

Rose E Goodchild1, William T Dauer.   

Abstract

Primary dystonia is a disease characterized by involuntary twisting movements caused by CNS dysfunction without underlying histopathology. DYT1 dystonia is a form of primary dystonia caused by an in-frame GAG deletion (DeltaE302/3) in the TOR1A gene that encodes the endoplasmic reticulum luminal protein torsinA. We show that torsinA is also present in the nuclear envelope (NE), where it appears to interact with substrate, and that the DeltaE302/3 mutation causes a striking redistribution of torsinA from the endoplasmic reticulum to the NE. In addition, DeltaE302/3-torsinA recruits WT torsinA to the NE, potentially providing insight into an understanding of the dominant inheritance of the disease. DYT1 dystonia appears to be a previously uncharacterized NE disease and the first, to our knowledge, to selectively affect CNS function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14711988      PMCID: PMC321769          DOI: 10.1073/pnas.0304375101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Concurrent chaperone and protease activities of ClpAP and the requirement for the N-terminal ClpA ATP binding site for chaperone activity.

Authors:  M Pak; J R Hoskins; S K Singh; M R Maurizi; S Wickner
Journal:  J Biol Chem       Date:  1999-07-02       Impact factor: 5.157

Review 2.  The inner nuclear membrane.

Authors:  H J Worman; J C Courvalin
Journal:  J Membr Biol       Date:  2000-09-01       Impact factor: 1.843

3.  Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C gene.

Authors:  G Bonne; E Mercuri; A Muchir; A Urtizberea; H M Bécane; D Recan; L Merlini; M Wehnert; R Boor; U Reuner; M Vorgerd; E M Wicklein; B Eymard; D Duboc; I Penisson-Besnier; J M Cuisset; X Ferrer; I Desguerre; D Lacombe; K Bushby; C Pollitt; D Toniolo; M Fardeau; K Schwartz; F Muntoni
Journal:  Ann Neurol       Date:  2000-08       Impact factor: 10.422

4.  AAA+: A class of chaperone-like ATPases associated with the assembly, operation, and disassembly of protein complexes.

Authors:  A F Neuwald; L Aravind; J L Spouge; E V Koonin
Journal:  Genome Res       Date:  1999-01       Impact factor: 9.043

5.  Torsin A and its torsion dystonia-associated mutant forms are lumenal glycoproteins that exhibit distinct subcellular localizations.

Authors:  K Kustedjo; M H Bracey; B F Cravatt
Journal:  J Biol Chem       Date:  2000-09-08       Impact factor: 5.157

6.  Mutations in ooc-5 and ooc-3 disrupt oocyte formation and the reestablishment of asymmetric PAR protein localization in two-cell Caenorhabditis elegans embryos.

Authors:  S E Basham; L S Rose
Journal:  Dev Biol       Date:  1999-11-15       Impact factor: 3.582

7.  Microtubule disassembly by ATP-dependent oligomerization of the AAA enzyme katanin.

Authors:  J J Hartman; R D Vale
Journal:  Science       Date:  1999-10-22       Impact factor: 47.728

8.  ClpA and ClpP remain associated during multiple rounds of ATP-dependent protein degradation by ClpAP protease.

Authors:  S K Singh; F Guo; M R Maurizi
Journal:  Biochemistry       Date:  1999-11-09       Impact factor: 3.162

9.  Mutant torsinA, responsible for early-onset torsion dystonia, forms membrane inclusions in cultured neural cells.

Authors:  J Hewett; C Gonzalez-Agosti; D Slater; P Ziefer; S Li; D Bergeron; D J Jacoby; L J Ozelius; V Ramesh; X O Breakefield
Journal:  Hum Mol Genet       Date:  2000-05-22       Impact factor: 6.150

Review 10.  AAA proteins. Lords of the ring.

Authors:  R D Vale
Journal:  J Cell Biol       Date:  2000-07-10       Impact factor: 10.539

View more
  119 in total

1.  A molecular mechanism underlying the neural-specific defect in torsinA mutant mice.

Authors:  Connie E Kim; Alex Perez; Guy Perkins; Mark H Ellisman; William T Dauer
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

Review 2.  A predictable worm: application of Caenorhabditis elegans for mechanistic investigation of movement disorders.

Authors:  Paige M Dexter; Kim A Caldwell; Guy A Caldwell
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

Review 3.  Genetic and clinical features of primary torsion dystonia.

Authors:  Laurie J Ozelius; Susan B Bressman
Journal:  Neurobiol Dis       Date:  2010-12-17       Impact factor: 5.996

Review 4.  Lentiviral vector-mediated gene transfer and RNA silencing technology in neuronal dysfunctions.

Authors:  Jean-Luc Dreyer
Journal:  Mol Biotechnol       Date:  2011-02       Impact factor: 2.695

Review 5.  Inner nuclear membrane proteins: impact on human disease.

Authors:  Iván Méndez-López; Howard J Worman
Journal:  Chromosoma       Date:  2012-02-04       Impact factor: 4.316

Review 6.  Interactions between nuclei and the cytoskeleton are mediated by SUN-KASH nuclear-envelope bridges.

Authors:  Daniel A Starr; Heidi N Fridolfsson
Journal:  Annu Rev Cell Dev Biol       Date:  2010       Impact factor: 13.827

Review 7.  Torsins: not your typical AAA+ ATPases.

Authors:  April E Rose; Rebecca S H Brown; Christian Schlieker
Journal:  Crit Rev Biochem Mol Biol       Date:  2015-10-13       Impact factor: 8.250

Review 8.  Inherited isolated dystonia: clinical genetics and gene function.

Authors:  William Dauer
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

Review 9.  The nuclear envelope: form and reformation.

Authors:  Amy J Prunuske; Katharine S Ullman
Journal:  Curr Opin Cell Biol       Date:  2005-12-20       Impact factor: 8.382

10.  Functional evidence implicating a novel TOR1A mutation in idiopathic, late-onset focal dystonia.

Authors:  Nicole Calakos; Viren D Patel; Melissa Gottron; Gaofeng Wang; Khan-Nhat Tran-Viet; Danielle Brewington; John L Beyer; David C Steffens; Ranga R Krishnan; Stephan Züchner
Journal:  J Med Genet       Date:  2009-12-02       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.